Buprenorphine/naloxone Oromucosal, Sublingual and Kisqali Femara Co-Pack 400 mg-2.5 mg Dose

• Generic Name: buprenorphine / naloxone
• Dosage Forms: n.a.
• Other Brand Names: Bunavail, Suboxone, Zubsolv

Buprenorphine and naloxone sublingual tablet is used to treat opioid (narcotic) dependence or addiction. Buprenorphine and naloxone buccal film, sublingual film, or sublingual tablet is used for induction and maintenance treatment of opioid (narcotic) dependence. It should be used in patients who have already been treated with buprenorphine sublingual tablets.

When a narcotic medicine is used for a long time, it may become habit-forming, causing mental or physical dependence. Physical dependence may lead to withdrawal side effects if the narcotic is stopped suddenly. Severe withdrawal side effects can usually be prevented when a person is switched to buprenorphine and naloxone combination. It acts on the central nervous system (CNS) to help prevent the withdrawal side effects.

Buprenorphine/naloxone is available only with your doctor's prescription.

• Generic Name: letrozole / ribociclib
• Dosage Forms: kit
• Other Brand Names: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose

Letrozole lowers estrogen levels, which may slow the growth of certain types of breast tumors that need estrogen to grow in the body.

Ribociclib interferes with the growth and spread of cancer cells in the body.

Kisqali Femara Co-Pack 400 mg-2.5 mg Dose are used together in combination to treat HR-positive, HER2-negative breast cancer in women.

Kisqali Femara Co-Pack 400 mg-2.5 mg Dose is used when the cancer has spread to other parts of the body (metastatic).

Kisqali Femara Co-Pack 400 mg-2.5 mg Dose are two different medicines that are packaged together. Letrozole tablets are yellow and ribociclib tablets are violet.

Kisqali Femara Co-Pack 400 mg-2.5 mg Dose may also be used for purposes not listed in this medication guide.